DVN
29
-3
PCAR
48
-2
O
40
5
CNX
50
-2
CTAS
45
3
KEY
57
-3
HP
49
-3
MAC
60
-4
RRC
60
-5
BRK.B
43
7
WMB
60
-3
AVB
64
4
CHK
32
-7
FSLR
47
-5
K
33
-2
COP
50
-4
EIX
61
5
PLD
68
4
WU
28
-4
ADT
35
-2
DVN
29
-3
PCAR
48
-2
O
40
5
CNX
50
-2
CTAS
45
3
KEY
57
-3
HP
49
-3
MAC
60
-4
RRC
60
-5
BRK.B
43
7
WMB
60
-3
AVB
64
4
CHK
32
-7
FSLR
47
-5
K
33
-2
COP
50
-4
EIX
61
5
PLD
68
4
WU
28
-4
ADT
35
-2
Financhill
Back

GT Biopharma Stock Price Chart

Buffet, Bloomberg & 48 Congress Members Are Buying 1 Sector

Click here for the details.
Sell
33

GTBP
GT Biopharma

Last Price:
2.88
Seasonality Move:
4.16%

7 Day Trial

ALL ACCESS PASS

$ 7

7 Stocks to Own Before the 2024 Election

Click the link below to get your copy. FREE
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing slight buying pressure.

GT Biopharma Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 2.86 Buy
20-day SMA: 2.94 Sell
50-day SMA: 3.37 Sell
200-day SMA: 5.43 Sell
8-day EMA: 2.85 Buy
20-day EMA: 3.01 Sell
50-day EMA: 3.38 Sell
200-day EMA: 6.92 Sell

GT Biopharma Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 45.36 Sell
Chaikin Money Flow: 5788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.76 - 3.38) Sell
Bollinger Bands (100): (3.04 - 4.54) Sell

GT Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for GT Biopharma Stock

Is GT Biopharma Stock a Buy?

  • GT Biopharma share price is 2.88 while GTBP 8-day simple moving average is 2.86, which is a Buy signal.
  • The stock price of GTBP is 2.88 while GT Biopharma 20-day SMA is 2.94, which makes it a Sell.
  • GT Biopharma 50-day simple moving average is 3.37 while GTBP share price is 2.88, making it a Sell technically.
  • GTBP stock price is 2.88 and GT Biopharma 200-day simple moving average is 5.43, creating a Sell signal.

GTBP Technical Analysis vs Fundamental Analysis

Sell
33
GT Biopharma (GTBP) is a Sell

Is GT Biopharma a Buy or a Sell?

  • GT Biopharma stock is rated a Sell
    The current GT Biopharma [GTBP] share price is $2.88. The Score for GTBP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.

GT Biopharma Stock Info

Market Cap:
4.08M
Price in USD:
2.88
Share Volume:
20.19K

GT Biopharma 52-Week Range

52-Week High:
10.95
52-Week Low:
2.60
Sell
33
GT Biopharma (GTBP) is a Sell

GT Biopharma Share Price Forecast

  • What is the GT Biopharma stock price today?
    The GT Biopharma stock price is 2.88 USD today.
  • Will GTBP stock go up or go down?
    GT Biopharma> share price is forecast to RISE/FALL based on technical indicators
  • Is GT Biopharma overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, GT Biopharma is overvalued.

Is GT Biopharma Stock a Buy?

  • GT Biopharma share price is 2.88 while GTBP 8-day exponential moving average is 2.85, which is a Buy signal.
  • The stock price of GTBP is 2.88 while GT Biopharma 20-day EMA is 3.01, which makes it a Sell.
  • GT Biopharma 50-day exponential moving average is 3.38 while GTBP share price is 2.88, making it a Sell technically.
  • GTBP stock price is 2.88 and GT Biopharma 200-day simple moving average is 6.92, creating a Sell signal.

Fundamental Analysis of GT Biopharma

Is GT Biopharma a good investment?

  • Analysts estimate an earnings decrease this quarter of $3.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.

Technical Analysis of GT Biopharma

Should I short GT Biopharma stock?

* GT Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.